Inicio › Enfermedad de obstrucción pulmonar crónica › Florida
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Florida
31 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Florida.
Ciudades en Florida
- Miami20 estudios
- Orlando15 estudios
- Hialeah10 estudios
- Tampa8 estudios
- West Palm Beach8 estudios
- Kendall7 estudios
- St. Petersburg6 estudios
- Deltona6 estudios
- Jacksonville6 estudios
- Ocala5 estudios
- Cape Coral5 estudios
- Naples4 estudios
- Doral4 estudios
- Brandon4 estudios
- Palm Coast3 estudios
- Coral Springs3 estudios
- Plantation3 estudios
- Clearwater3 estudios
- Boca Raton3 estudios
Texto oficial del estudio (inglés)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Doral
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07780669A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- GSK Investigational Site, Cape Coral
- GSK Investigational Site, Greenacres City
- GSK Investigational Site, Miami
- y 1 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07780656A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50011, Miami
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07725939Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
- Family First Medical Research Center ( Site 4458), Hialeah Gardens
- Advanced Pulmonary Research Institute ( Site 4427), Loxahatchee Groves
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07874815A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Millennium Medical Research - Miami, Miami
- Deluxe Health Center, Miami Lakes
- Florida Institute For Clinical Research, LLC, Orlando
ReclutandoFase 2
Edades de 40 a 75 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07759245Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Mayo Clinic Jacksonville, Jacksonville
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07051707Rademikibart IV for Acute Asthma and COPD Exacerbation
- Pharmax Research of South Florida, Inc., Miami
ReclutandoFase 2
Edades de 18 a 85 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07705737A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
- C&A Clinical Trials Corp, Cape Coral
- Continental Clinical Research, LLC, Miami
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07908381To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- International Clinical Research, Altamonte Springs
- Synergy Healthcare, LLC, Bradenton
- K2 Medical Research Winter Garden LLC, Clermont
- y 4 más
ReclutandoFase 2
Edades de 40 a 85 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07684820A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 103, Gainesville
- GC2501 Study Site 105, Miami
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 26 oct 2026 · NCT07555483A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Brandon
- Research Site, Cape Coral
- Research Site, Clearwater
- y 17 más
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Meris Clinical Research- Site Number : 8400153, Brandon
- Hillcrest Medical Research- Site Number : 8400082, DeLand
- Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
- y 18 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Jacksonville
- WB Contracted Clinical Research Site, Miami Lakes
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07646587A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Finlay Medical Research, Greenacres City
- Clinical Research Specialists LLC, Kissimmee
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- y 9 más
ReclutandoFase 2/3
Edades de 35 a 80 · Todos los sexos · Actualizado el 22 oct 2026 · NCT07363694A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
ReclutandoFase 4
Edades de 40 a 85 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07053423Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Mayo Clinic, Jascksonville
- Orlando Health, Orlando
Reclutando
Edades de 40 a 84 · Todos los sexos · Actualizado el 19 oct 2026 · NCT06891755Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Helix Biomedics- Site Number : 8400065, Boynton Beach
- Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
- Eastern Medical Group Research- Site Number : 8400020, Fort Myers
- y 11 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07190209Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for Pulmonary Diseases
- Prodromos Stem Cell Institute, Naples
ReclutandoFase 1
Todas las edades · Todos los sexos · Actualizado el 16 oct 2026 · NCT05147688STRIVE Post-Market Registry Study
- University of Miami, Coral Gables
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT04302272A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Bay Pines
- Research Site, Boynton Beach
- Research Site, Jacksonville
- y 4 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Brooksville
- GSK Investigational Site, Doral
- GSK Investigational Site, Fort Lauderdale
- y 16 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Bradenton
- GSK Investigational Site, Brandon
- GSK Investigational Site, Hialeah
- y 12 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Boynton Beach
- Research Site, Bradenton
- Research Site, Cape Coral
- y 25 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06283966An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Orlando Health, Orlando
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06035120Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Florida, Jacksonville
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Clearwater
- Research Site, Cutler Bay
- Research Site, Cutler Bay
- y 9 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305Alpha-1 Research Registry
- Alpha-1 Foundation, Coral Gables
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 19 ago 2026 · NCT04157049eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Brandon
- GSK Investigational Site, Crystal River
- GSK Investigational Site, Doral
- y 8 más
ReclutandoFase 3
Edades de 40 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07177339Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- University of Miami, Miami
Reclutando
Edades de 18 a 100 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06578156Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hillcrest Medical Research, DeLand
- Universal Axon Clinical Research, Doral
- I.H.S Health, LLC, Kissimmee
- y 3 más
ReclutandoEstudio observacional
Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Florida, Jacksonville, Jacksonville
- Alloy Clinical Research, Kissimmee
- Reliable Research, Inc., Miami
- y 2 más
Reclutando
Edades de 30 en adelante · Todos los sexos · Actualizado el 6 feb 2025 · NCT05204888De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.